A(z) 300210 HR/KN-kód hatályon kívül az EUDR-előkészítés szempontjából.
Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes Az indexelt hatálymotor Out of scope eredményt ad erre a kódra. No Annex I scope match was found for this indexed CN code.
Miért ezt a választ adja ez a referenciaoldal.
- Kódleírás
- Antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes
- I. melléklet szerinti alap
- Nincs közvetlen I. melléklet szerinti bejegyzés
- Forrásalap
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Szülő-, gyermek- és szomszédos sorok.
A könyvtárnézet a referencianavigációt szolgálja. Használja az ellenőrzőt, ha egy másik kódot műveletként szeretne futtatni.
30pharmaceutical productsout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021091haemoglobin, blood globulins and serum globulins(2012-2016);haemoglobin, blood globulins and serum globulins(2002-2011);haemoglobin, blood globulins and serum globulins(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out300211malaria diagnostic test kitsout300212antisera and other blood fractionsout300213immunological products, unmixed, not put up in measured doses or in forms or packings for retail saleout300214immunological products, mixed, not put up in measured doses or in forms or packings for retail saleout300215immunological products, put up in measured doses or in forms or packings for retail saleout300219immunological products, n.e.s. (code possibly empty, preceding subheadings seem exhaustive)out
Mit jelent ez az előkészítés szempontjából.
Ez a sor nem közvetlen bizonyítékgyűjtési kiváltó a jelenlegi hatályeredményben.
Regulation (EU) 2023/1115 Annex I — relevant productslekérve: 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115lekérve: 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)lekérve: 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)lekérve: 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8lekérve: 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkinglekérve: 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and traderslekérve: 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)lekérve: 2026-08-08